Open an account

DocGo

DCGO · NASDAQ

$0.2591+$0.0042 (+1.65%)TodayMarket closed ·
Prev close $0.2549

About DCGO

DocGo, Inc. engages in the provision of mobile health services. The company is headquartered in New York City, New York and currently employs 2,537 full-time employees. The company went IPO on 2020-10-15. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.

Employees
3,053
Headquarters
New York City, New York
Listed
Oct 15, 2020
Sector
Health Care
Industry
Health Care Providers & Services
Website
docgo.com

DCGO key statistics

Market cap
25.65M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
639.99K
Volume
183.23K
Open price
$0.251
High today
$0.2641
Low today
$0.25
52 Week high
$1.65
52 Week low
$0.2408

DocGo (DCGO) at a glance

DocGo (DCGO) last traded at $0.2591, with a market cap of 25.65M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.25 and $0.2641. The current price is 3.6% above the day's low and 1.9% below its high.

Volume so far is 183.23K shares, below the average of 639.99K shares a day.

Over the past year DocGo has ranged from $0.2408 to $1.65, and now sits 1% of the way up that range.

DocGo met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.16 per share against an estimate of -$0.0632.

The average analyst price target is $1.94, 648.0% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

75%of 4 analyst ratings say Buy
  • Buy75.0%
  • Hold25.0%
  • Sell0.0%
Price target · 7 analystsAvg $1.94
Low
$1.01
Now
$0.2591
High
$3.15

DCGO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 2.6% on average.

  1. Q3 FY24: reported $0.05 per share against an estimate of $0.0495
  2. Q4 FY24: reported $0.04 per share against an estimate of $0.0495
  3. Q1 FY25: reported -$0.09 per share against an estimate of -$0.0219
  4. Q2 FY25: reported -$0.11 per share against an estimate of -$0.0962
  5. Q3 FY25: reported -$0.113 per share against an estimate of -$0.118
  6. Q4 FY25: reported -$1.37 per share against an estimate of -$0.1343
  7. Q1 FY26: reported -$0.13 per share against an estimate of -$0.0952
  8. Q2 FY26: reported -$0.16 per share against an estimate of -$0.0632

DCGO news

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition

  • Press releaseBusiness Wire

    DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Transcript: DocGo Q2 2026 Earnings Conference Call

  • Press releaseBusiness Wire

    DocGo Announces Second Quarter 2026 Results

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releaseBusiness Wire

    DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026

Similar companies

Companies in the same industry as DocGo

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.